2024

We are delighted to announce that ZAS Corporation has successfully obtained the trademark for our brand Protimeal. Registered under trademark no. 216979, effective from November 15, 2017, this certification covers all goods under class 30. This achievement highlights our dedication to protecting the integrity of our products and ensuring that Protimeal continues to provide trusted […]

We are proud to announce the successful launch of Celltrion’s biosimilar products in Bangladesh, marking a significant milestone in our commitment to advancing healthcare in the nation. This launch represents not just the introduction of new treatments but the beginning of a new era in patient care, driven by innovation and quality. Our launch campaign

Dhaka, Bangladesh – ZAS Corporation Ltd., a leading pharmaceutical company with a strong focus on oncology, recently held a transformative sales conference and recreation tour for their oncology team. The event, titled “A Decade Long Destiny – Unfolding Future,” was a significant milestone, bringing together team members to engage in knowledge sharing sessions, recreational activities,

ZAS Corporation, in collaboration with the Bangladesh Society of Critical Care Medicine (BSCCM), recently organized a scientific seminar focused on “Hypophosphatemia and Re-feeding Syndrome.” The event featured a compelling case presentation and an interactive Q&A session, marking the successful launch of Polymyxin B. Renowned ICU doctors shared their expert knowledge on the complexities of hypophosphatemia

ZAS Corporation Ltd. has pledged its support to the 4th International Scientific Conference of Bangladesh Perinatal Society, reinforcing its dedication to enhancing neonatal care worldwide. With a firm commitment to the health and well-being of mothers and newborns, ZAS joins forces with esteemed global experts to champion this critical cause. Through collaborative efforts and innovative

In a groundbreaking collaboration, the Bangladesh Endocrine Society (BES) joined forces with medical experts to conduct a Continuing Medical Education (CME) session delving into the current perspective of Gonadal Hormone Replacement Therapy (GHRT). This significant initiative aimed to enhance understanding and practice in the realm of endocrine health, ultimately striving for improved patient care across

In a promising stride towards combating respiratory infections, ZAS Corporation Ltd. joined hands with the Bangladesh Lung Foundation to pioneer a groundbreaking Scientific Seminar on Recurrent Respiratory Tract Infection (RTI) Prevention. Held in a collaborative effort to explore the potential of Lyophilized Bacterial Lysates, the seminar illuminated innovative pathways for effective healthcare solutions.